Table 2. Characteristics of 264 children and adolescents stratified by viral load suppression at follow up in 2018 (N = 264).
| 2018–children and adolescents on ART | Total sampled (264) | Viral load (copies/ml) | Unadjusted Odds Ratio [95% CI] | Adjusted Odds Ratio [95% CI] | p-value | ||
|---|---|---|---|---|---|---|---|
| <1000 n = 215 |
> = 1000 n = 49 |
||||||
| Age | <10 years | 70(27%) | 57(81%) | 13(19%) | - | ||
| 10 to 15 years | 88(33%) | 78(89%) | 10(11%) | 1.78 [0.73–4.34] |
1.37 [0.52–3.60] |
0.528 | |
| >than 15 years | 106(40%) | 80(75%) | 26(25%) | 0.70 [0.33–1.48] |
0.51 [0.22–1.17] |
0.109 | |
| Gender | Female | 144(55%) | 121(84%) | 23(16%) | 0.329 | ||
| Male | 120(45%) | 94(78%) | 26(22%) | 0.69 [0.37–1.28] |
0.73 [0.38–1.38] |
||
| Site | Chidamoyo site | 134(51%) | 105(78%) | 29(22%) | 0.156 | ||
| Outreach site | 130(49%) | 110(85%) | 20(15%) | 1.52 [0.81–2.85] |
1.60 [0.83–3.09] |
||
| ART line | NNRTI | 150(57%) | 129(86%) | 21(14%) | 0.024 | ||
| PI | 114(43%) | 86(75%) | 28(25%) | 0.50 [0.27–0.94] |
0.44 [0.22–0.90] |
||
| Care giver | Both parents | 31(13%) | 23(74%) | 8(26%) | |||
| Single parent | 127(52%) | 106(83%) | 21(17%) | 1.76 [0.69–4.45] |
|||
| Not parent | 88(36%) | 71(81%) | 17(19%) | 1.45 [0.55–3.81] |
|||
|
CD4* (cells/mm3) at follow-up |
<500 | 45(29%) | 32(71%) | 13(29%) | |||
| ≥500 | 111(71%) | 95(86%) | 16(14%) | 2.41 [1.05–5.56] |
|||
| Weight | Median (IQR) | 33 (26–46) |
34 (26–46) |
34 (25–48) |
1.00 [0.97–1.03] |
||
| 2018 Duration on ART (years) | Median (IQR) | 7.0 (5.2–8.2) |
7.2 (5.4–8.2) |
6.4 (4.6–7.9) |
1.07 [0.93–1.21] |
||
ART-Antiretroviral therapy; IQR- Interquartile range
*CD4 numbers were obtained for 156/264 (59%)